Projects per year
Search results
-
Active
PRiZM+: A phase II Platform study for Relapsed and Refractory prImary CNS lymphoma with Zanubrutinib
Boucher, B., Jackson, A., Fox, S. & Craddock, C.
1/04/22 → 30/06/26
Project: Research
-
REFRACT (CR-UK): A Sequential Randomised Phase II Trial in Relapsed Follicular comparing standard Chemotherapy with Novel agents
Jackson, A., Fox, S., Gaskell, C. & McIlroy, G.
Genmab A/S, Cancer Research Uk
1/02/22 → 31/07/32
Project: Research
-
FEDORA: A phase II study to evaluate the safety, toxicity and tolerability of the combination of fedratinib and ropeginterferon alfa-2b, in patients with myelofibrosis
Fox, S., Craddock, C. & Jackson, A.
AOP Orphan Pharmaceuticals GmbH
31/12/21 → 30/06/26
Project: Research
-
FEDORA - A phase II study to evaluate the tolerability, safety and activity of fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis
Jackson, A., Fox, S. & Craddock, C.
3/12/21 → 30/06/26
Project: Industry
-
A randomised phase 2 study of ASTX727 versus best supportive care in MDS/MPN Overlap Syndromes
Fox, S., Boucher, B., Craddock, C. & Jackson, A.
1/03/21 → 31/08/25
Project: Research
-
FaR-RMS - An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma
Bowden, S., Kearns, P., Gatz, S., Pirrie, S., Jackson, A., Liu, W. & Gaunt, P.
1/01/21 → 30/06/31
Project: EU
-
PACE: The impact of COVID-19 on patients with AML undergoing chemotherapy: an epidemiological study
Jackson, A., Craddock, C., Loke, J., Boucher, B. & Fox, S.
CELGENE INTERNATIONAL II SARL, BLOODWISE
1/04/20 → 30/06/25
Project: Research
-
COSI: An international randomised clinical trial of therapeutic interventions with the potential to improve outcome in adults with acute myeloid leukaemia and high risk myelodysplasia undergoing allogeneic stem cell transplantation
Craddock, C. & Jackson, A.
Jazz Pharmaceuticals, ADIENNE s.r.l
1/09/19 → 31/12/26
Project: Industry
-
STELLAR: A Phase 2, Randomised Study of CHOP-R in Combination with acalabrutinib followed by acalabrutinib maintenance compared to CHOP-R followed by acalabrutinib at disease progression for patients...
Craddock, C., Jackson, A., Boucher, B., Siddique, S. & Wheatley, K.
7/12/18 → 6/06/26
Project: Research
-
HR-MB: An international High-Risk Medulloblastoma trial
Lawson, A., Kearns, P., Gates, S., Gaunt, P., Pirrie, S., Billingham, L., Homer, V., Jackson, A. & Slade, D.
Cancer Research Uk, SIOP Europe
1/10/18 → 30/09/29
Project: Research
-
AMADEUS - Double-blind,IMPACT phase III,Randomised Study to Compare the Efficacy and Safety to Oral AZA(CC-486)Versus Placebo in Subject with Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance after Allogeneic Haematopoieti
Craddock, C., Siddique, S. & Jackson, A.
1/04/18 → 31/03/28
Project: Industry
-
CRUK/17/011 FaR-RMS: A multiarm-multistage study for children and adults with localised and metastatic frontline and relapsed RhabdoMyoSarcoma.
Kearns, P., Gatz, S., Liu, W., Gaunt, P., Jackson, A. & Pirrie, S.
Cancer Research Uk, SIOP Europe
1/02/18 → 31/01/28
Project: Research
-
A Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T)
Siddique, S., Jackson, A. & Craddock, C.
6/07/17 → 31/12/24
Project: Industry
-
PHAZAR/RuxAza - A phase Ib study to assess the safety and tolerability of oral Ruxolitinib in combination with 5 azacitidine in patients with accelerated phase MPNs, MDS or AML after MPNs
Siddique, S., Fox, S., Fenwick, N. & Jackson, A.
BLOODWISE, CELGENE INTERNATIONAL SARL, NOVARTIS PHARMACEUTICALS UK LTD
1/04/14 → 31/12/24
Project: Research